Replay available

Anika Therapeutics Inc. (ANIK) Q2 2026 Earnings Call

Anika Therapeutics Inc. (NASDAQ: ANIK) Q2 2026 earnings conference call, held 2026-07-29. Replay captured from the company's public earnings webcast.

Wed, July 29, 2026 at 8:30 AMendedReplay
Anika Therapeutics Inc. (ANIK) Q2 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Matt Hall

Executive Director, Corporate Development and Investor Relations at Anika

Steve Griffin

President and Chief Executive Officer at Anika

Ian MacLeod

Senior Vice President, Chief Accounting Officer and Treasurer at Anika

Anderson Shock

at B

Mike Petusky

at Barrington Research

Replay transcript excerpt

Good morning, ladies and gentlemen, and welcome to the Anika's Second Quarter Earnings Conference Call. I would now like to turn the call over to Mr. Matt Hall, Executive Director, Corporate Development and Investor Relations. Please proceed. Good morning, and thank you for joining us for Anika's second quarter twenty twenty six conference call and webcast. I'm Matt Hall, Anika's Executive Director of Corporate Development and Investor Relations. Our earnings press release was issued earlier this morning and is available on our Investor Relations website located at www.anika.com as the supplementary PowerPoint slides that will be used for the discussion today. With me on the call are Steve Griffin, President and Chief Executive Officer and Ian MacLeod, Senior Vice President, Chief Accounting Officer and Treasurer. They will present our second quarter twenty twenty six financial results and business highlights. Please take a moment and open the slide presentation and refer to Slide two. Before we begin, please understand that certain statements made during today's call constitute forward looking statements as defined in the Securities Exchange Act of 1934. These statements are based on our current beliefs and expectations and are subject to certain risks and uncertainties. The company's actual results could differ materially from any anticipated future results, performance or achievements. We make no obligation to update these statements should future financial data or events occur that differ from the forward looking statements presented today. Please also see our most recent SEC filings for more information about risk factors that could affect our performance. In addition, during the call, we may refer to several adjusted or non GAAP financial measures, which may in...

More from Anika Therapeutics Inc.